Sermorelin & GHRP-6 Blend (10mg) – Premium Research Peptide Blend for Pituitary Studies

Welcome to Liaocheng Yixin Company, your trusted source for premium sermorelin ghrp-6 blend 10mg for research. As a specialized peptide synthesis manufacturer operating from our facility in Shandong Province, China, we provide high-quality research compounds for the global scientific community.

This blend combines Sermorelin (GRF 1-29), a biologically active fragment of growth hormone-releasing hormone (GHRH), with GHRP-6, a synthetic hexapeptide ghrelin receptor agonist . Together, they represent a mechanistically synergistic tool for investigating growth hormone (GH) axis regulation in vitro . Our sermorelin ghrp-6 blend 10mg for research offers investigators a reliable, high-purity compound for pituitary function and endocrine signaling studies.

What is the Sermorelin & GHRP-6 Blend?

This research blend combines two complementary peptides with distinct signaling pathways, both converging on pituitary somatotrophs :

Sermorelin (GRF 1-29)

• GHRH receptor agonist (class B GPCR)

• Activates Gs/adenylyl cyclase/cAMP/PKA pathway

• Stimulates both acute GH release and GH gene transcription

• Preserves normal GH pulsatility and feedback regulation 

GHRP-6

• Ghrelin receptor (GHS-R1a) agonist

• Activates Gq/PLC/IP3/PKC pathway

• Triggers calcium mobilization and GH exocytosis

• Suppresses somatostatin release 

Key Identifiers:

• Molecular Formula (Sermorelin): C149H246N44O42S

• Molecular Weight (Sermorelin): ~2,093 g/mol

• Molecular Formula (GHRP-6): C46H56N12O6

• Molecular Weight (GHRP-6): ~873.03 g/mol 

• Purity: ≥99% verified by HPLC

Mechanism of Action in Research

Synergistic Receptor Activation

The blend’s research value lies in its dual-pathway design. Sermorelin mimics endogenous GHRH by activating GHRH receptors on anterior pituitary somatotrophs, engaging the cAMP/PKA signaling cascade to stimulate GH gene transcription and exocytosis . Simultaneously, GHRP-6 binds GHS-R1a receptors, activating the PLC/IP3/PKC pathway .

Convergent Signaling

When both pathways are activated concurrently, the result is a synergistic amplification of GH pulse amplitude that substantially exceeds the additive effect of either agent alone. GHRP-6 also acts centrally to stimulate appetite through hypothalamic ghrelin receptor activation . Additionally, GHRP-6-mediated somatostatin suppression extends the window during which GHRH can act, further amplifying GH pulse amplitude and duration .

Scientific Research Applications

Growth Hormone Axis Studies

The blend is used to investigate the synergistic interaction between GHRH and ghrelin pathways in pituitary models. Research demonstrates that combined administration of GHRH analogs and GHRPs produces GH responses substantially greater than either peptide alone . In one study, GHRP-6 alone produced a peak GH response of approximately 60 mU/L, while combined GHRP-6 and GHRH analog administration raised the peak to approximately 140 mU/L .

IGF-1 Signaling Studies

Insulin-like growth factor-1 (IGF-1) serves as a surrogate marker for GH activity. In a retrospective study of hypogonadal men treated with a combination of GHRP-6, GHRP-2, and SERM at 100 mcg each three times daily, mean IGF-1 levels increased from a baseline of 159.5 ± 26.7 ng/mL to 239.0 ± 54.6 ng/mL (p < .0001) after a mean treatment duration of 134 days . This approximately 50% increase demonstrates the potential of GHRP/Sermorelin combination therapy to elevate IGF-1 levels .

Endocrine Feedback Research

The blend preserves normal GH pulsatility and feedback regulation, distinguishing it from exogenous GH administration which suppresses endogenous production . This makes it valuable for investigating hypothalamic-pituitary-somatotropic axis function and feedback mechanisms.

Receptor Synergy Studies

The blend allows researchers to evaluate dual-receptor stimulation in somatotroph systems. When both receptor families are activated simultaneously, GH output rises beyond what is seen with either pathway alone, enabling investigation of additive or synergistic coupling at the pituitary signaling level .

Why Choose Liaocheng Yixin Company?

When sourcing sermorelin ghrp-6 blend 10mg for research, quality and reliability are paramount. Here’s why researchers trust us:

Manufacturer-Direct Quality

We are a legitimate, licensed peptide synthesis company with a physical headquarters in Shandong Province, China. Our facility maintains strict quality control standards.

Verified Purity Standards

Every batch undergoes rigorous testing using HPLC analysis. Certificates of Analysis are available upon request.

Research-Grade Specifications

• Purity: ≥99% verified by HPLC

• Appearance: White lyophilized powder

• Storage: Store powder at -20°C in a sealed container, protected from light and moisture

• Form: Lyophilized powder for research use

Quality Assurance & Testing

Every batch undergoes comprehensive quality control:

1. Synthesis by experienced chemists using solid-phase peptide synthesis

2. Purification via preparative HPLC

3. Analysis using HPLC for purity verification

4. Mass Spectrometry for molecular weight confirmation

5. Packaged in sterile conditions for research use

When you need premium sermorelin ghrp-6 blend 10mg for research for your pituitary function, endocrine signaling, or receptor synergy studies, choose a manufacturer that prioritizes quality, transparency, and reliability. Liaocheng Yixin Company combines expert peptide synthesis capabilities with rigorous quality control to deliver research materials you can trust.